ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
4.585
-0.235 (-4.88%)
Apr 28, 2026, 4:00 PM EDT - Market closed
ENDRA Life Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 3.91 | 7.63 | 5.52 | 6.6 | 6.02 | |
| Research & Development | 1.85 | 3.19 | 5 | 6.55 | 5.48 | |
| Operating Expenses | 5.76 | 10.82 | 10.52 | 13.16 | 11.5 | |
| Operating Income | -5.76 | -10.82 | -10.52 | -13.16 | -11.5 | |
| Other Non Operating Income (Expenses) | -1.27 | -3.77 | 0.46 | -0.02 | -0.04 | |
| EBT Excluding Unusual Items | -7.03 | -14.58 | -10.06 | -13.18 | -11.54 | |
| Other Unusual Items | 0.01 | 3.08 | - | - | 0.31 | |
| Pretax Income | -7.03 | -11.51 | -10.06 | -13.18 | -11.23 | |
| Net Income | -7.03 | -11.51 | -10.06 | -13.18 | -11.23 | |
| Preferred Dividends & Other Adjustments | - | - | - | - | 0.12 | |
| Net Income to Common | -7.03 | -11.51 | -10.06 | -13.18 | -11.35 | |
| Shares Outstanding (Basic) | 1 | 0 | - | - | - | |
| Shares Outstanding (Diluted) | 1 | 0 | - | - | - | |
| Shares Change (YoY) | 289.41% | - | - | - | - | |
| EPS (Basic) | -8.93 | -56.94 | - | - | - | |
| EPS (Diluted) | -8.93 | -56.94 | - | - | - | |
| Free Cash Flow | -5.2 | -7.42 | -9.58 | -12.97 | -11.17 | |
| Free Cash Flow Per Share | -6.61 | -36.70 | - | - | - | |
| EBITDA | -5.72 | -10.77 | -10.4 | -13.06 | -11.38 | |
| D&A For EBITDA | 0.04 | 0.05 | 0.12 | 0.1 | 0.12 | |
| EBIT | -5.76 | -10.82 | -10.52 | -13.16 | -11.5 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.